We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App




Two Automated Hematology Analyzers Compared for Performance

By LabMedica International staff writers
Posted on 17 Dec 2020
Print article
Image: The Yumizen H2500 Automatic Hematology Analyzer (Photo courtesy of Horiba)
Image: The Yumizen H2500 Automatic Hematology Analyzer (Photo courtesy of Horiba)
A complete blood count (CBC) is a highly automated laboratory test. The use of highly advanced measurement methods increases the accuracy and sensitivity of the determination of individual hematological parameters, especially in the case of white blood cells differentiation.

It is important that the results of laboratory tests obtained using automated analyzers, which are currently able to perform more than 1,000 tests per day, are comparable, repeatable and reliable regardless of the analyzer used and the laboratory in which the analysis was performed.

Medical Laboratorians at the Medical University of Warsaw (Warsaw, Poland) collected 241 peripheral blood samples from adult patients. Samples of peripheral blood came from both healthy patients and those suffering from various pathologies. To perform comparative analysis of hematological parameters, complete blood count with leukocyte differentiation (CBC+ 5-DIFF) and a complete blood count (CBC) without leukocyte differentiation were used.

The complete blood count results were obtained using two automated hematology analyzers: the XN-2000 (Sysmex Corporation, Kobe, Japan) and the Yumizen H2500 (Horiba, Kyoto, Japan). The XN-2000 uses the following methods of fluorescent flow to determine all tested hematological parameters: cytometry, impedance and optical cytometry. Impedance method to count red blood cells (RBC) and platelets, and has an optical measurement channel for reticulocytes in which platelet count can also be measured. The Yumizen H2500 is a quantitative, multi-parameter, automatic hematological analyzer. It uses the double hydrodynamic focusing method, which includes measurement of polychromatic light absorbance and the impedance method.

The scientists reported that reliable leukocyte differentiation results were obtained for blood samples in which the number of white blood cells perceived using an automatic hematological analyzer was within the detection limits for both analyzers. Statistically significant differences were found for four hematological parameters: eosinophil count, immature granulocytes, mean corpuscular hemoglobin concentration (MCHC) and platelet distribution width (PDW).

The comparative study showed agreement between measurements of complete blood count parameters such as leukocyte count (WBC), red blood cell count (RBC), hemoglobin concentration (HGB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (mean cell hemoglobin, MCH), red blood cell distribution width (RDW), platelet count (PLT), mean platelet volume (MPV), and plateletcrit (PCT).

The authors concluded that due to the existence of variability between the results obtained from different hematology analyzers, it is recommended that patient samples be analyzed in the same laboratory using the same analyzer, in order to avoid obtaining divergent results that could be misinterpreted. Incorrect interpretation may affect further clinical management and be a source of uncertainty. The study was published in the November, 2020 issue of the journal Practical Laboratory Medicine.

Related Links:
Medical University of Warsaw
Sysmex Corporation
Horiba


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Human Placenta DNA
Human Placenta DNA
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.